US20110121033A1 - Skincare Treatment - Google Patents
Skincare Treatment Download PDFInfo
- Publication number
- US20110121033A1 US20110121033A1 US12/811,705 US81170508A US2011121033A1 US 20110121033 A1 US20110121033 A1 US 20110121033A1 US 81170508 A US81170508 A US 81170508A US 2011121033 A1 US2011121033 A1 US 2011121033A1
- Authority
- US
- United States
- Prior art keywords
- composition
- anhydrous
- skin
- compositions
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 claims abstract description 230
- 206010000496 acne Diseases 0.000 claims abstract description 76
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 62
- 239000004480 active ingredient Substances 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 35
- 239000008365 aqueous carrier Substances 0.000 claims abstract description 9
- 238000002955 isolation Methods 0.000 claims abstract description 6
- 238000011200 topical administration Methods 0.000 claims abstract description 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 66
- 239000004094 surface-active agent Substances 0.000 claims description 34
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 33
- 229960004889 salicylic acid Drugs 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 27
- -1 alkyl sulphates Chemical class 0.000 claims description 25
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 23
- 239000002480 mineral oil Substances 0.000 claims description 23
- 235000010446 mineral oil Nutrition 0.000 claims description 21
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 10
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 150000002430 hydrocarbons Chemical class 0.000 claims description 7
- 239000010457 zeolite Substances 0.000 claims description 7
- 229910001507 metal halide Inorganic materials 0.000 claims description 6
- 150000005309 metal halides Chemical class 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 5
- 239000003410 keratolytic agent Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 3
- 239000004711 α-olefin Substances 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 229920001577 copolymer Polymers 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000002562 thickening agent Substances 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 210000002374 sebum Anatomy 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 229910021653 sulphate ion Inorganic materials 0.000 description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 229920001451 polypropylene glycol Polymers 0.000 description 6
- 150000003839 salts Chemical group 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229920006122 polyamide resin Polymers 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 4
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 2
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 2
- 229960002916 adapalene Drugs 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229960002255 azelaic acid Drugs 0.000 description 2
- 229960003328 benzoyl peroxide Drugs 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- GADGVXXJJXQRSA-UHFFFAOYSA-N ethenyl 8-methylnonanoate Chemical compound CC(C)CCCCCCC(=O)OC=C GADGVXXJJXQRSA-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229960000565 tazarotene Drugs 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CUAJPFGLNDCFAH-UHFFFAOYSA-N 1,1-di(propan-2-yl)cyclohexane Chemical compound CC(C)C1(C(C)C)CCCCC1 CUAJPFGLNDCFAH-UHFFFAOYSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- OAOABCKPVCUNKO-UHFFFAOYSA-M 8-methylnonanoate Chemical compound CC(C)CCCCCCC([O-])=O OAOABCKPVCUNKO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 244000151018 Maranta arundinacea Species 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052936 alkali metal sulfate Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- WOQQAWHSKSSAGF-WXFJLFHKSA-N decyl beta-D-maltopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WOQQAWHSKSSAGF-WXFJLFHKSA-N 0.000 description 1
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- TVWTZAGVNBPXHU-FOCLMDBBSA-N dioctyl (e)-but-2-enedioate Chemical compound CCCCCCCCOC(=O)\C=C\C(=O)OCCCCCCCC TVWTZAGVNBPXHU-FOCLMDBBSA-N 0.000 description 1
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- 229940093446 oleth-5 Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940086560 pentaerythrityl tetrastearate Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001987 poloxamine Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- GUQPDKHHVFLXHS-UHFFFAOYSA-M sodium;2-(2-dodecoxyethoxy)ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOS([O-])(=O)=O GUQPDKHHVFLXHS-UHFFFAOYSA-M 0.000 description 1
- HVFAVOFILADWEZ-UHFFFAOYSA-M sodium;2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCN(CCO)CC([O-])=O HVFAVOFILADWEZ-UHFFFAOYSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940098780 tribehenin Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/242—Exothermic; Self-heating; Heating sensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Definitions
- the present invention relates to a method of treating acne, to an acne treatment kit, to compositions and kits useful in such methods and to processes to prepare said composition and/or kits.
- Acne vulgaris is a chronic inflammatory condition of the pilosebaceous units of the skin, which is particularly prevalent in adolescents.
- the condition generally causes the formation, on the skin, of comedones, red papules, pustules and sometimes cysts. This is unsightly and furthermore, if untreated, acne can lead to scarring of the skin.
- the major causes of acne are thought to be an increase in sebum production, an increased presence of Propionibacterium acne ( P. acne ), blockage of the pilosebaceus duct and the production of inflammation.
- Remedies for the topical treatment of acne generally provide for the application to the affected area of a skincare composition comprising at least one ingredient effective to treat acne.
- actives include the classes of topical retinoids, antibiotics, anti-bacterials and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide and salicylic acid.
- an improved acne treatment may be achieved by the topical administration of an acne active ingredient in the presence of a component that generates heat on the skin.
- the present invention provides a method of treating acne comprising the topical administration of an acne active ingredient in the presence of
- the present invention also provides an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.
- the present invention provides a skincare formulation obtained by mixing on, or prior to application to, the skin comprising
- anhydrous composition for the treatment of acne comprising an acne active ingredient, a component that in the presence of water generates heat and a carrier therefor.
- the invention also provides an acne treatment package for dispensing a first and a second composition onto the skin, said first composition being anhydrous and comprising a component that in the presence of water generates heat and said second composition comprising an aqueous component, at least one of said compositions comprising an acne active ingredient, wherein said package comprises a first chamber and a second chamber, each of said first and second chambers having an outlet, wherein said first composition is stored in said first chamber and said second composition is stored in said second chamber, said compositions being stored in isolation from each other and the package being arranged such that said first and second compositions are combined after passing though each respective outlet.
- the invention also provides a process of dispensing an acne treatment onto the skin comprising the application to the skin of a first composition which is anhydrous and comprises a component that in the presence of water generates heat, and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, and mixing said compositions to generate heat on the skin.
- the invention also provides a process to prepare an acne treatment kit, comprising inserting a first composition which is anhydrous and comprises a component that in the presence of water generates heat into a first chamber of a multi-chambered package and inserting a second composition which comprises an aqueous carrier into a second chamber of said package, at least one of said compositions comprising an acne active ingredient, and providing means for combining said compositions on, or prior to application to, the skin.
- anhydrous composition means a composition which is substantially free of water; for example, it will contain less than 2% by weight water preferably less than 1% by weight water and most preferably less than 0.1% by weight water.
- an acne active ingredient is applied to the skin in the presence of an anhydrous composition comprising a component that in the presence of water generates heat and water.
- the heat is generated on the skin and is useful to raise the temperature on the surface of the skin.
- the amount of heat-generating component present in the anhydrous composition is a level that the heat generated by the combination of the anhydrous composition with the water is acceptable on the skin of a user and does not burn the skin.
- the anhydrous composition may be applied to the skin and water applied thereto.
- the water may be applied before, at the same time as, or after the application of the anhydrous composition.
- the anhydrous composition and water are combined by rubbing the ingredients together. In this way the heat generating component is most effectively combined with water to provide a heating effect on the skin.
- the water may be obtained from any suitable source, for example a water tap.
- the water may also be provided in an aqueous composition which may include one or more additional ingredients, especially skincare ingredients. There may be sufficient water already present on the skin to produce a suitable heating effect if the anhydrous composition is rubbed into the skin with sufficient vigour.
- the aqueous composition forms part of a package in combination with the anhydrous composition, which allows a measured amount of water to be applied to the skin thus allowing more control of the heating effect.
- the administration of the anhydrous composition and the aqueous composition on the skin is substantially simultaneous.
- the anhydrous composition and aqueous composition may be combined just prior to application to the skin or they may be combined on the skin.
- the anhydrous composition and aqueous composition may be dispensed from separate chambers within a package. The outlet of each chamber may allow the compositions to be applied directly onto the skin and then combined by the user rubbing the compositions on the surface of the skin or the compositions may be combined as they pass through a dispensing nozzle before application to the skin.
- a skincare formulation is provided when said anhydrous composition is combined with water. Heat is generated on the skin which enhances the effect of the acne active ingredient.
- the skincare formulation may be left on the skin in which case the heat generated will gradually subside.
- the composition is rinsed off the skin, leaving a therapeutically effective amount of the acne active ingredient on the skin.
- the acne active ingredient may be present separate from the anhydrous composition or the aqueous composition, it may be present in either the anhydrous and aqueous compositions or it may be present in both the anhydrous and aqueous compositions.
- the acne active ingredient may be selected from any class of materials that are effective to treat acne, including topical retinoids, antibiotics, anti-microbials, anti-bacterials, anti-inflammatory agents and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide, hydrogen peroxide and salicylic acid. If desired two or more acne active ingredients may be employed. The active ingredients may be present in the same or in different compositions.
- the active ingredient is present in the formulation in a therapeutically effective amount, as generally known in the art. For most active ingredients, a range from 0.001% to 10% by weight, especially from 0.1% to 10% by weight, could be expected. Thus, generally each composition may comprise the above recited amount of acne active ingredient.
- an acne active ingredient is present in an amount of 0.1% to 5% by weight of the anhydrous composition.
- an acne active ingredient is present in an amount of 0.1% to 5% by weight of the aqueous composition.
- an acne active ingredient is present in an amount from 0.1% to 5% by weight of both aqueous and anhydrous compositions.
- said acne active ingredient is a keratolytic agent such as salicylic acid.
- Salicylic acid is preferably incorporated into the composition according to the invention as the free acid.
- the pH of the composition may, and generally will, be such that the salicylic acid exists in the composition in dissociated form.
- the composition may well contain cationic counterions, the salicylic acid may then be thought of as being present in salt form.
- the salicylic acid may be incorporated into the composition in salt form, eg as a salt with a Group I metal, such as sodium salicylate.
- any and all references to salicylic acid should be taken to encompass references to the acid and to dissociated forms and salts thereof.
- the total concentration of salicylic acid in the formulation according to the invention is preferably at least 0.1% by weight, more preferably at least 0.5% by weight, most preferably at least 1.0% and especially at least 1.5% by weight.
- the concentration of salicylic acid is preferably less than 10% by weight, more preferably less than 6% by weight, and most preferably less than 4% by weight.
- the total concentration of salicylic acid may fall in the range 0.1% to 10% by weight, preferably 0.5% to 10% by weight, more preferably 1.0% to 6%, and most preferably 1.5% to 4.0% by weight.
- a particularly preferred total concentrations of salicylic acid is approximately 1.5-2% by weight of the composition.
- said acne active ingredient preferably salicylic acid
- said acne active ingredient is present in the anhydrous and aqueous compositions.
- the amount of acne active ingredient may be different in each composition.
- the aqueous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
- the anhydrous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
- any pharmaceutically acceptable component that generates heat in the presence of water may be used.
- Preferred examples are selected from the group of materials that generate heat within the classes of zeolites (aluminosilicates); metal halides, sulphates, carbonates and oxides; and polyhydric alcohols.
- Preferred classes of materials include zeolites and bivalent metal halides. These materials are well known to those skilled in the art. Examples of bivalent metal halides and oxides may include magnesium chloride, iron chloride, zinc chloride, magnesium oxide, calcium oxide, magnesium sulphate and calcium chloride.
- Such heat generating materials will suitably be present in the anhydrous composition in an amount to heat the skin to facilitate opening and cleansing of the pores.
- such materials my be used in an amount of up to 70% by weight of the anhydrous composition, for example, from 1% to 70% by weight, preferably from 1% to 40% by weight, more preferably from 1% to 25% by weight and most preferably from 1% to 15% by weight.
- the heat generated must be less than that which will cause heat damage to the skin.
- the temperature of the skin is raised by no more than 50° C.
- the temperature of the skin is raised by at least 2° C., more preferably at least 10° C.
- the temperature of the skin may be raised to a temperature in the range 4° C. to 70° C., preferably 4° C. to 15° C.
- the component that in the presence of water generates heat comprises a bivalent metal halide, further preferably a metal halide selected from magnesium chloride, iron chloride, zinc chloride and calcium chloride, most preferably magnesium chloride.
- the anhydrous composition comprises from 5% to 60% by weight, preferably from 10% to 50% by weight, more preferably from 12% to 40% by weight and most preferably from 15% to 35% by weight of said water-activatable, heat-generating component.
- the anhydrous composition comprises an anhydrous carrier.
- this may be an oily material.
- a physiologically effective oil useful in accordance with the present invention may be any cosmetically and/or dermatologically acceptable synthetic or natural oil known to the person skilled in the art. Such oils may also provide emollient properties on the skin, for example to maintain the soft, smooth and pliable appearance of the skin.
- Suitable ingredients include hydrocarbons, silicone oils, triglycerides, waxes, fatty acids, fatty acid alcohols and esters thereof, mineral oils, vegetable oils and hydrogenated vegetable oils, lanolin or mixtures thereof.
- hydrocarbons examples include paraffins (for example paraffinum liquidum and white soft paraffin), petrolatum, hydrogenated polyisobutene, alkyl benzoates, isohexadecane, isododecane, isononyl isonanoate, diisopropylcyclohexane;
- silicone oils include dimethicone, cyclomethicone or cetyldimethicone;
- triglycerides include natural triglycerides and synthetic or semi-synthetic triglycerides;
- waxes include vegetable waxes such as carnauba wax, animal waxes such as beeswax, and mineral waxes such as paraffin wax, ozokerite;
- esters of fatty acids or alcohols include isopropyl palmitate, isopropyl myristate, dioctylmaleate, glyceryl oleate and cetostearyl isononanoate, oct
- Such materials may be used in an amount greater than 30% by weight, more preferably greater than 35% by weight, advantageously greater than 40% by weight and most preferably greater than 45% by weight of the composition.
- the carrier generally provides the largest component by weight of the anhydrous composition.
- the anhydrous composition comprises from 30% to 99% by weight, preferably from 35% to 95% by weight, more preferably from 40% to 90% by weight and most preferably from 50% to 85% by weight of said carrier.
- the anhydrous carrier comprises a mineral oil.
- the mineral oil is blended with a styrene copolymer, for example a hydrogenated alkylene-styrene copolymer, more preferably a hydrogenated butylene/ethylene/styrene copolymer or a hydrogenated ethylene/propylene/styrene copolymer or a mixture thereof.
- a particularly preferred source of a mineral oil/styrene copolymer blend is available under the tradename Versagel from Penreco, 138 Petrolia Karns City USA.
- mineral oil is combined with a hydrogenated alkylene-styrene copolymer/mineral oil blend.
- the total mineral oil is preferably present in an amount from 50% to 85% by weight, more preferably from 60% to 80% by weight, of the anhydrous composition; conveniently this may be a blend comprising mineral oil in an amount from 25% to 60% by weight (more preferably from 35% to 50% by weight) and a mineral oil/styrene copolymer blend in an amount from 20% to 40% by weight (more preferably from 24% to 32% by weight).
- the anhydrous composition comprises a surfactant.
- a surfactant This forms a particularly preferred aspect of the present invention as it provides a composition with advantageous viscosity and skin-feel properties. For example, it may provide a less oily feel to the composition so that it is more pleasant to apply and retain on the skin. For example, a greasy and/or oily and/or sticky feel on the skin may be reduced.
- the inclusion of a surfactant in a composition where the carrier is a hydrocarbon (such as mineral oil) improves the aesthetic feel of the composition on the skin. In this way, it has been found that less expensive carriers may be employed in the anhydrous composition.
- the anhydrous composition has good viscosity properties as it is not too viscous to apply and does not run off the skin when applied thereto.
- a suitable viscosity is that of a thickened liquid such that it is thicker than water and preferably remains in the area to which it is applied, even when the user moves or applies it to a non-horizontal skin surface.
- the compositions have a viscosity which allow them to be dispensed conveniently from a package, especially through a dispensing nozzle.
- the viscosity range values of such compositions will be known to those skilled in the art.
- the inclusion of at least one surfactant may provide that it may not be necessary to include a thickening component in the composition.
- the anhydrous composition comprises a surfactant and does not include a thickening component.
- the surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art.
- non-ionic surfactants include the class of ethoxylated fatty alcohols and other surfactants such as oleth-5, PEG-5 cocamide, polysorbate 20, PEG-40 hydrogenated castor oil, alkyl poly(ethylene oxide), copolymers of poly(ethylene oxide) and poly(propylene oxide) (commercially called Poloxamers or Poloxamines), alkyl polyglucosides, including: octyl glucoside, decyl maltoside, fatty alcohols, cetyl alcohol, oleyl alcohol;
- anionic surfactants includes the class of alkyl ether sulphates, such as sodium lauryl sulphate, sodium laureth sulphate, sodium dodecyl sul
- the surfactant comprises an anionic surfactant, optionally in combination with other surfactants.
- the surfactant comprises an alkali metal sulphate, such as sodium lauryl sulphate and/or sodium dodecyl sulphate.
- the anhydrous composition comprises from 1-20% by weight surfactant, further preferably from 1% to 10% by weight, more preferably from 3% to 15% by weight and most preferably from 4% to 10% by weight surfactant.
- the present invention provides an anhydrous composition comprising
- the anhydrous composition consists essentially of the above ingredients.
- the aqueous composition is a cleansing composition comprising a surfactant.
- the surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Particular surfactants may be as described above with respect to the anhydrous composition.
- the surfactant comprises an anionic surfactant and/or a non-ionic surfactant.
- Preferred materials include lauryl or laureth sulphates (such as sodium or triethanolamine lauryl/laureth sulphates) and polypropyleneglycols, polyethylene glycols and derivatives thereof.
- the total surfactant concentration in the aqueous and anhydrous compositions when combined to provide the formulation is sufficient such that when rubbed into the skin, a foam is produced which can be rinsed off the skin.
- aqueous and anhydrous compositions may also include other skincare ingredients as desired, for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
- other skincare ingredients for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
- anhydrous and aqueous compositions may also comprise thickening agents which increase the viscosity of the composition.
- thickening agents include polyethylene glycols; polyoxyethylene cetyl ethers; Acrylates/Vinyl Isodecanoate crosspolymer, polyamide resins such as Sylvaclear (tradename), lanolin, stearyl alcohol and salt.
- the present invention provides an aqueous composition comprising
- the aqueous composition consists essentially of the above ingredients.
- the anhydrous and/or aqueous compositions comprise from 1-20% by weight thickener, more preferably from 2% to 15% by weight and most preferably from 3% to 10% by weight thickener.
- aqueous and anhydrous compositions provided in accordance with the present invention are suitably in the form of a liquid or a gel, preferably as a viscous liquid.
- the anhydrous and aqueous compositions may comprise other conventional ingredients, such as anti-microbial agents, sequestering agents, colouring agents and perfumes.
- Such ingredients and the amounts in which they are incorporated in the composition are within the knowledge of those skilled in the art.
- the present invention also provides an acne treatment package for storing and dispensing the above described aqueous and anhydrous compositions onto the skin.
- the package comprises a first chamber and a second chamber, each chamber having an outlet thereto, wherein said anhydrous composition is stored in said first chamber and said aqueous composition is stored in said second chamber, said compositions being stored in isolation from each other and being arranged to be combined after passing though said respective outlets onto the skin. On combination of the compositions, heat is generated, effective to raise the temperature of the skin.
- each composition passes through the outlet of the chamber in which it is stored.
- the outlets may be adjacent so that on expelling the compositions from the package at the same time, they may be combined after they pass through the outlets onto the skin. It may be desired however to expel the compositions separately, for example to apply one composition and then target the second composition in the area of the first composition. In this case it is not necessary that the outlets of each chamber are near to each other. Although a heating effect is obtained as soon as the water comes into contact with the component that generates heat on contact with water, it is preferred to mix the compositions by rubbing them into the skin.
- the package further comprises a dispensing nozzle through which the combined compositions are dispensed onto the skin.
- the aqueous and anhydrous compositions may be combined in the dispensing nozzle or a chamber leading thereto and then targeted onto the affected area of the skin.
- the package comprises a receptacle partitioned into first and second chambers.
- the package comprises a dispensing nozzle in which the aqueous and anhydrous compositions may be combined before being expelled onto the skin.
- the package comprises a tube comprising an anhydrous or aqueous composition and an inner tube comprising the other of said anhydrous or aqueous composition.
- the inner tube is encompassed within an outer tube which forms the packaging.
- the package is squeezable to expel said anhydrous or aqueous compositions.
- a method according to the invention including a method of treating acne comprising the topical administration of an acne active ingredient in the presence of a component that in the presence of water generates heat, may be a therapeutic method, but will often be a primarily cosmetic method, the objective of which is to reduce or eliminate externally visible, and often unsightly, symptoms of acne.
- FIG. 1 shows a side view of a package comprising an inner tube containing a first composition located within a clear outer tube containing a second composition;
- FIG. 2 shows a perspective view of one end of a tube comprising a first dispensing nozzle
- FIG. 3 shows an end view of a second dispensing nozzle
- FIG. 4 shows a sectional view of a partitioned package comprising first and second chambers
- FIG. 5 shows an expanded perspective view of the dispensing nozzle from a partitioned package.
- an acne treatment package ( 2 ) for dispensing first and second compositions onto the skin comprises an outer tube ( 4 ) which provides a first chamber and an inner tube ( 6 ) which provides a second chamber, the contents of the first chamber being isolated from the second chamber.
- the outer tube has a cap ( 8 ).
- An aqueous composition which comprises an acne active ingredient is stored in said first (outer) chamber and an anhydrous composition which comprises an acne active ingredient and a component that in the presence of water generates heat on the skin is stored in said second (inner) chamber.
- the anhydrous composition is present in the outer tube and the aqueous composition is present in the inner tube.
- the acne active ingredient is present in either one of the anhydrous or aqueous compositions.
- At least one surfactant is present in either one of or both of the anhydrous and aqueous compositions.
- the package comprises a neck which forms a dispensing nozzle ( 10 ).
- the inner tube has an outlet leading into a central channel ( 12 ) of the dispensing nozzle.
- the outer tube has an outlet leading to a plurality of openings ( 14 ) around the periphery of the dispensing nozzle.
- the dispensing nozzle ( 10 ) is placed on or near the affected area of the skin and the outer and inner tubes squeezed simultaneously.
- the anhydrous composition is expelled through the central channel ( 12 ) and the aqueous composition is expelled from the plurality of openings ( 14 ).
- the compositions are expelled from the package they are combined as they pass onto the skin.
- the combined compositions are rubbed together into the skin which causes heat to be generated.
- the combined formulation is then rinsed from the skin.
- FIG. 3 shows an embodiment where the central passage ( 12 ) is enlarged towards the periphery of the dispensing nozzle and allows a greater amount of the composition in the inner tube to be expelled at a given time in relation to the amount of composition expelled from the openings ( 14 ) in the outer tube.
- FIG. 4 shows a section view of a partitioned package ( 16 ) providing first ( 18 ) and second ( 20 ) chambers.
- the anhydrous composition is stored in the first chamber ( 18 ).
- the aqueous composition is stored in the second chamber ( 20 ).
- FIG. 5 shows a perspective view of one end of the partitioned package ( 16 ) which is in the form of a tube.
- the package comprises a neck which forms a dispensing nozzle ( 22 ).
- the dispensing nozzle is divided down the middle to form two semi-circular channels.
- a first channel connects the first chamber ( 18 ) with a dispensing aperture ( 24 ).
- a second channel connects the second chamber ( 20 ) with a dispensing aperture ( 26 ).
- the dispensing nozzle ( 10 ) When it is desired to apply the combined compositions to the skin, the dispensing nozzle ( 10 ) is placed on or near the affected area of the skin and the tube ( 16 ) squeezed. The anhydrous composition is expelled from the aperture ( 24 ) and the aqueous composition is expelled from the aperture ( 26 ). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
- the ingredients are available as follows; Carrier 1 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer is available from Penreco under the trade name Versagel M-1600; Carrier 2 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer and is available from Penreco under the trade name Versagel R-500; Thickener 1 is a combination of Glyceryl Dibehenate, Tribehenin and Glyceryl Behenate and is available form Gattefosse under the tradename Compritol ATO 888; Thickener 2 is polyoxyethylene cetyl ether available under the tradename Brij 56; Acrylates/Vinyl Isodecanoate crosspolymer is available from 3V under the tradename Stabylen-30; The polyamide resin is available from Arizona Chemical under the tradename Syl
- any one of the heating compositions illustrated below may be combined with any of the aqueous compositions illustrated below.
- the compositions are rubbed together on the skin and after a desired period may be rinsed off.
- a sheet of vitro-skin was accurately cut using a guillotine into 10 equal pieces. Each of these pieces was then numbered and weighed before the addition of sebum. Sebum was added to the skin as a solid that could be rubbed across the whole of the skin surface (matte side) until the whole surface was covered ( ⁇ 0.2 g). Each piece of skin was then weighed once more before being placed in the hydration chamber.
- the hydration chamber was prepared by adding a mixture of Glycerine (44 g) and DI water (256 g) to the bottom of it. The skin was then placed on the contained shelves and allowed to stand, with the lid tightly in place for approximately 24 hours at ambient conditions in order to ensure a realistic level of vitro-skin hydration.
- the lid was removed and cleansing tests were carried out on the skin.
- the vitro-skin was placed on a foam surface to mimic the non-solidity of skin.
- the vitro-skin was left to dry on the shelves provided in the hydration chamber.
- test samples were:
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
- The present invention relates to a method of treating acne, to an acne treatment kit, to compositions and kits useful in such methods and to processes to prepare said composition and/or kits.
- Acne vulgaris (acne) is a chronic inflammatory condition of the pilosebaceous units of the skin, which is particularly prevalent in adolescents. The condition generally causes the formation, on the skin, of comedones, red papules, pustules and sometimes cysts. This is unsightly and furthermore, if untreated, acne can lead to scarring of the skin. The major causes of acne are thought to be an increase in sebum production, an increased presence of Propionibacterium acne (P. acne), blockage of the pilosebaceus duct and the production of inflammation.
- Remedies for the topical treatment of acne generally provide for the application to the affected area of a skincare composition comprising at least one ingredient effective to treat acne. Such actives include the classes of topical retinoids, antibiotics, anti-bacterials and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide and salicylic acid.
- It has now been found that an improved acne treatment may be achieved by the topical administration of an acne active ingredient in the presence of a component that generates heat on the skin.
- It has been found that the above treatment provides improved efficacy in the topical treatment of acne. For example, factors including improved sebum removal and improved pore cleansing may lead to a reduction in the number and intensity of acne lesions.
- Accordingly, the present invention provides a method of treating acne comprising the topical administration of an acne active ingredient in the presence of
-
- a) an anhydrous composition comprising a component that in the presence of water generates heat on the skin, and
- b) water.
- In another aspect the present invention also provides an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.
- In a yet further aspect the present invention provides a skincare formulation obtained by mixing on, or prior to application to, the skin comprising
-
- a) a first composition which is anhydrous and comprises a component that in the presence of water generates heat;
- b) a second composition which comprises an aqueous carrier; and
- c) at least one acne active ingredient.
- In still a further aspect the present invention provides an anhydrous composition for the treatment of acne comprising an acne active ingredient, a component that in the presence of water generates heat and a carrier therefor.
- The invention also provides an acne treatment package for dispensing a first and a second composition onto the skin, said first composition being anhydrous and comprising a component that in the presence of water generates heat and said second composition comprising an aqueous component, at least one of said compositions comprising an acne active ingredient, wherein said package comprises a first chamber and a second chamber, each of said first and second chambers having an outlet, wherein said first composition is stored in said first chamber and said second composition is stored in said second chamber, said compositions being stored in isolation from each other and the package being arranged such that said first and second compositions are combined after passing though each respective outlet.
- The invention also provides a process of dispensing an acne treatment onto the skin comprising the application to the skin of a first composition which is anhydrous and comprises a component that in the presence of water generates heat, and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, and mixing said compositions to generate heat on the skin.
- The invention also provides a process to prepare an acne treatment kit, comprising inserting a first composition which is anhydrous and comprises a component that in the presence of water generates heat into a first chamber of a multi-chambered package and inserting a second composition which comprises an aqueous carrier into a second chamber of said package, at least one of said compositions comprising an acne active ingredient, and providing means for combining said compositions on, or prior to application to, the skin.
- Where reference is made herein to an anhydrous composition, this means a composition which is substantially free of water; for example, it will contain less than 2% by weight water preferably less than 1% by weight water and most preferably less than 0.1% by weight water.
- In a method according to the invention, an acne active ingredient is applied to the skin in the presence of an anhydrous composition comprising a component that in the presence of water generates heat and water. The heat is generated on the skin and is useful to raise the temperature on the surface of the skin. The amount of heat-generating component present in the anhydrous composition is a level that the heat generated by the combination of the anhydrous composition with the water is acceptable on the skin of a user and does not burn the skin.
- In accordance with the present invention, the anhydrous composition may be applied to the skin and water applied thereto. The water may be applied before, at the same time as, or after the application of the anhydrous composition. Preferably the anhydrous composition and water are combined by rubbing the ingredients together. In this way the heat generating component is most effectively combined with water to provide a heating effect on the skin.
- The water may be obtained from any suitable source, for example a water tap. The water may also be provided in an aqueous composition which may include one or more additional ingredients, especially skincare ingredients. There may be sufficient water already present on the skin to produce a suitable heating effect if the anhydrous composition is rubbed into the skin with sufficient vigour.
- Preferably, the aqueous composition forms part of a package in combination with the anhydrous composition, which allows a measured amount of water to be applied to the skin thus allowing more control of the heating effect.
- In one embodiment, the administration of the anhydrous composition and the aqueous composition on the skin is substantially simultaneous. The anhydrous composition and aqueous composition may be combined just prior to application to the skin or they may be combined on the skin. For example, the anhydrous composition and aqueous composition may be dispensed from separate chambers within a package. The outlet of each chamber may allow the compositions to be applied directly onto the skin and then combined by the user rubbing the compositions on the surface of the skin or the compositions may be combined as they pass through a dispensing nozzle before application to the skin.
- A skincare formulation is provided when said anhydrous composition is combined with water. Heat is generated on the skin which enhances the effect of the acne active ingredient. The skincare formulation may be left on the skin in which case the heat generated will gradually subside. Preferably the composition is rinsed off the skin, leaving a therapeutically effective amount of the acne active ingredient on the skin.
- The acne active ingredient may be present separate from the anhydrous composition or the aqueous composition, it may be present in either the anhydrous and aqueous compositions or it may be present in both the anhydrous and aqueous compositions.
- The acne active ingredient may be selected from any class of materials that are effective to treat acne, including topical retinoids, antibiotics, anti-microbials, anti-bacterials, anti-inflammatory agents and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide, hydrogen peroxide and salicylic acid. If desired two or more acne active ingredients may be employed. The active ingredients may be present in the same or in different compositions.
- The active ingredient is present in the formulation in a therapeutically effective amount, as generally known in the art. For most active ingredients, a range from 0.001% to 10% by weight, especially from 0.1% to 10% by weight, could be expected. Thus, generally each composition may comprise the above recited amount of acne active ingredient. Preferably, an acne active ingredient is present in an amount of 0.1% to 5% by weight of the anhydrous composition. Further preferably, an acne active ingredient is present in an amount of 0.1% to 5% by weight of the aqueous composition. However, it may be a benefit to reduce the total amount of any one active in the anhydrous or aqueous compositions, or to separate a plurality of actives, by including at least one acne active ingredient in both compositions. Thus, in a preferred embodiment, an acne active ingredient is present in an amount from 0.1% to 5% by weight of both aqueous and anhydrous compositions.
- In one embodiment, said acne active ingredient is a keratolytic agent such as salicylic acid. Salicylic acid is preferably incorporated into the composition according to the invention as the free acid. However, the pH of the composition may, and generally will, be such that the salicylic acid exists in the composition in dissociated form. As the composition may well contain cationic counterions, the salicylic acid may then be thought of as being present in salt form. Alternatively, the salicylic acid may be incorporated into the composition in salt form, eg as a salt with a Group I metal, such as sodium salicylate. As used herein, unless the context requires otherwise, any and all references to salicylic acid should be taken to encompass references to the acid and to dissociated forms and salts thereof.
- The total concentration of salicylic acid in the formulation according to the invention, ie the combined anhydrous and aqueous compositions, is preferably at least 0.1% by weight, more preferably at least 0.5% by weight, most preferably at least 1.0% and especially at least 1.5% by weight. The concentration of salicylic acid is preferably less than 10% by weight, more preferably less than 6% by weight, and most preferably less than 4% by weight. Conveniently, the total concentration of salicylic acid may fall in the range 0.1% to 10% by weight, preferably 0.5% to 10% by weight, more preferably 1.0% to 6%, and most preferably 1.5% to 4.0% by weight. A particularly preferred total concentrations of salicylic acid is approximately 1.5-2% by weight of the composition.
- In one embodiment, said acne active ingredient, preferably salicylic acid, is present in the anhydrous and aqueous compositions. The amount of acne active ingredient may be different in each composition. However, preferably, the aqueous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient. Further preferably, the anhydrous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
- In accordance with the invention, any pharmaceutically acceptable component that generates heat in the presence of water may be used. Preferred examples are selected from the group of materials that generate heat within the classes of zeolites (aluminosilicates); metal halides, sulphates, carbonates and oxides; and polyhydric alcohols. Preferred classes of materials include zeolites and bivalent metal halides. These materials are well known to those skilled in the art. Examples of bivalent metal halides and oxides may include magnesium chloride, iron chloride, zinc chloride, magnesium oxide, calcium oxide, magnesium sulphate and calcium chloride.
- Such heat generating materials will suitably be present in the anhydrous composition in an amount to heat the skin to facilitate opening and cleansing of the pores. For example, such materials my be used in an amount of up to 70% by weight of the anhydrous composition, for example, from 1% to 70% by weight, preferably from 1% to 40% by weight, more preferably from 1% to 25% by weight and most preferably from 1% to 15% by weight.
- The person skilled in the art will appreciate that the heat generated must be less than that which will cause heat damage to the skin. Preferably the temperature of the skin is raised by no more than 50° C. In order to be effective, preferably, the temperature of the skin is raised by at least 2° C., more preferably at least 10° C. Conveniently, the temperature of the skin may be raised to a temperature in the
range 4° C. to 70° C., preferably 4° C. to 15° C. - Preferably, the component that in the presence of water generates heat comprises a bivalent metal halide, further preferably a metal halide selected from magnesium chloride, iron chloride, zinc chloride and calcium chloride, most preferably magnesium chloride.
- In one embodiment of the invention, the anhydrous composition comprises from 5% to 60% by weight, preferably from 10% to 50% by weight, more preferably from 12% to 40% by weight and most preferably from 15% to 35% by weight of said water-activatable, heat-generating component.
- In accordance with the invention, the anhydrous composition comprises an anhydrous carrier. Conveniently, this may be an oily material. A physiologically effective oil useful in accordance with the present invention may be any cosmetically and/or dermatologically acceptable synthetic or natural oil known to the person skilled in the art. Such oils may also provide emollient properties on the skin, for example to maintain the soft, smooth and pliable appearance of the skin. Suitable ingredients include hydrocarbons, silicone oils, triglycerides, waxes, fatty acids, fatty acid alcohols and esters thereof, mineral oils, vegetable oils and hydrogenated vegetable oils, lanolin or mixtures thereof. Examples of hydrocarbons include paraffins (for example paraffinum liquidum and white soft paraffin), petrolatum, hydrogenated polyisobutene, alkyl benzoates, isohexadecane, isododecane, isononyl isonanoate, diisopropylcyclohexane; examples of silicone oils include dimethicone, cyclomethicone or cetyldimethicone; examples of triglycerides include natural triglycerides and synthetic or semi-synthetic triglycerides; examples of waxes include vegetable waxes such as carnauba wax, animal waxes such as beeswax, and mineral waxes such as paraffin wax, ozokerite; examples of esters of fatty acids or alcohols include isopropyl palmitate, isopropyl myristate, dioctylmaleate, glyceryl oleate and cetostearyl isononanoate, octyl palmitate; examples of mineral oils include Vaseline oil; examples of vegetable oils include jojoba oil, soy bean oil, coconut oil, sunflower seed oil, apricot kernel oil, shea butter, avocado oil and examples of hydrogenated vegetable oils include hydrogenated palm oil.
- Such materials may be used in an amount greater than 30% by weight, more preferably greater than 35% by weight, advantageously greater than 40% by weight and most preferably greater than 45% by weight of the composition. The carrier generally provides the largest component by weight of the anhydrous composition. Preferably, the anhydrous composition comprises from 30% to 99% by weight, preferably from 35% to 95% by weight, more preferably from 40% to 90% by weight and most preferably from 50% to 85% by weight of said carrier.
- In one embodiment, the anhydrous carrier comprises a mineral oil. Preferably, the mineral oil is blended with a styrene copolymer, for example a hydrogenated alkylene-styrene copolymer, more preferably a hydrogenated butylene/ethylene/styrene copolymer or a hydrogenated ethylene/propylene/styrene copolymer or a mixture thereof. A particularly preferred source of a mineral oil/styrene copolymer blend is available under the tradename Versagel from Penreco, 138 Petrolia Karns City USA.
- Preferably, mineral oil is combined with a hydrogenated alkylene-styrene copolymer/mineral oil blend.
- In preferred compositions which comprise mineral oil, the total mineral oil is preferably present in an amount from 50% to 85% by weight, more preferably from 60% to 80% by weight, of the anhydrous composition; conveniently this may be a blend comprising mineral oil in an amount from 25% to 60% by weight (more preferably from 35% to 50% by weight) and a mineral oil/styrene copolymer blend in an amount from 20% to 40% by weight (more preferably from 24% to 32% by weight).
- In another embodiment, the anhydrous composition comprises a surfactant. This forms a particularly preferred aspect of the present invention as it provides a composition with advantageous viscosity and skin-feel properties. For example, it may provide a less oily feel to the composition so that it is more pleasant to apply and retain on the skin. For example, a greasy and/or oily and/or sticky feel on the skin may be reduced. In particular, the inclusion of a surfactant in a composition where the carrier is a hydrocarbon (such as mineral oil) improves the aesthetic feel of the composition on the skin. In this way, it has been found that less expensive carriers may be employed in the anhydrous composition. Furthermore, the anhydrous composition has good viscosity properties as it is not too viscous to apply and does not run off the skin when applied thereto. A suitable viscosity is that of a thickened liquid such that it is thicker than water and preferably remains in the area to which it is applied, even when the user moves or applies it to a non-horizontal skin surface. It is a preferred feature of the invention that the compositions have a viscosity which allow them to be dispensed conveniently from a package, especially through a dispensing nozzle. The viscosity range values of such compositions will be known to those skilled in the art. The inclusion of at least one surfactant may provide that it may not be necessary to include a thickening component in the composition. In one embodiment, the anhydrous composition comprises a surfactant and does not include a thickening component.
- The surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Examples of non-ionic surfactants include the class of ethoxylated fatty alcohols and other surfactants such as oleth-5, PEG-5 cocamide,
polysorbate 20, PEG-40 hydrogenated castor oil, alkyl poly(ethylene oxide), copolymers of poly(ethylene oxide) and poly(propylene oxide) (commercially called Poloxamers or Poloxamines), alkyl polyglucosides, including: octyl glucoside, decyl maltoside, fatty alcohols, cetyl alcohol, oleyl alcohol; examples of anionic surfactants includes the class of alkyl ether sulphates, such as sodium lauryl sulphate, sodium laureth sulphate, sodium dodecyl sulfate, ammonium lauryl sulfate, ammonium laureth sulphate, sodium C12-15 pareth sulphate and disodium laureth sulfosuccinate, soaps or fatty acid salts; examples of cationic surfactants include cationic modified guar, alkyltrimethylammonium salts, for example cetrimonium chloride, cetyl trimethylammonium bromide, cetylpyridinium chloride, polyethoxylated tallow amine, benzalkonium chloride, benzethonium chloride and behentrimonium chloride; examples of amphoteric surfactants include the class of alkylamido alkyl amines and dodecyl betaine, dodecyl dimethylamine oxide, cocamidopropyl betaine, cocamidopropyl hydroxysultaine, sodium lauroamphoacetate, cocoamphoglycinate or sodium cocoamphoacetate. A further preferred group of classes of surfactants are alkyl sulphates, alkyl ether sulphates, alpha-olefin sulphates, alkylsarcosinates and aryl-sulphonated derivatives thereof. - Preferably, the surfactant comprises an anionic surfactant, optionally in combination with other surfactants. Most preferably, the surfactant comprises an alkali metal sulphate, such as sodium lauryl sulphate and/or sodium dodecyl sulphate.
- Preferably, when present, the anhydrous composition comprises from 1-20% by weight surfactant, further preferably from 1% to 10% by weight, more preferably from 3% to 15% by weight and most preferably from 4% to 10% by weight surfactant.
- In one embodiment, the present invention provides an anhydrous composition comprising
-
- (a) 1% to 5% by weight salicylic acid;
- (b) 10% to 35% by weight magnesium chloride;
- (c) 4% to 10% by weight surfactant; and
- (d) 50% to 85% by weight carrier.
- Further preferably, the anhydrous composition consists essentially of the above ingredients.
- In one embodiment of the present invention, the aqueous composition is a cleansing composition comprising a surfactant. The surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Particular surfactants may be as described above with respect to the anhydrous composition. Preferably, the surfactant comprises an anionic surfactant and/or a non-ionic surfactant. Preferred materials include lauryl or laureth sulphates (such as sodium or triethanolamine lauryl/laureth sulphates) and polypropyleneglycols, polyethylene glycols and derivatives thereof.
- In preferred compositions, it is desired that the total surfactant concentration in the aqueous and anhydrous compositions when combined to provide the formulation, is sufficient such that when rubbed into the skin, a foam is produced which can be rinsed off the skin.
- The aqueous and anhydrous compositions may also include other skincare ingredients as desired, for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
- In particular, the anhydrous and aqueous compositions may also comprise thickening agents which increase the viscosity of the composition. Examples include polyethylene glycols; polyoxyethylene cetyl ethers; Acrylates/Vinyl Isodecanoate crosspolymer, polyamide resins such as Sylvaclear (tradename), lanolin, stearyl alcohol and salt.
- In one embodiment, the present invention provides an aqueous composition comprising
-
- (a) 1% to 5% by weight salicylic acid;
- (b) 5% to 85% by weight surfactant; and
- (c) 10% to 94% by weight water.
- Further preferably, the aqueous composition consists essentially of the above ingredients.
- Preferably, when present, the anhydrous and/or aqueous compositions comprise from 1-20% by weight thickener, more preferably from 2% to 15% by weight and most preferably from 3% to 10% by weight thickener.
- The aqueous and anhydrous compositions provided in accordance with the present invention are suitably in the form of a liquid or a gel, preferably as a viscous liquid.
- In accordance with the present invention, the anhydrous and aqueous compositions may comprise other conventional ingredients, such as anti-microbial agents, sequestering agents, colouring agents and perfumes. Such ingredients and the amounts in which they are incorporated in the composition are within the knowledge of those skilled in the art.
- The present invention also provides an acne treatment package for storing and dispensing the above described aqueous and anhydrous compositions onto the skin. The package comprises a first chamber and a second chamber, each chamber having an outlet thereto, wherein said anhydrous composition is stored in said first chamber and said aqueous composition is stored in said second chamber, said compositions being stored in isolation from each other and being arranged to be combined after passing though said respective outlets onto the skin. On combination of the compositions, heat is generated, effective to raise the temperature of the skin.
- In expelling a portion of the contents of the package, each composition passes through the outlet of the chamber in which it is stored. The outlets may be adjacent so that on expelling the compositions from the package at the same time, they may be combined after they pass through the outlets onto the skin. It may be desired however to expel the compositions separately, for example to apply one composition and then target the second composition in the area of the first composition. In this case it is not necessary that the outlets of each chamber are near to each other. Although a heating effect is obtained as soon as the water comes into contact with the component that generates heat on contact with water, it is preferred to mix the compositions by rubbing them into the skin.
- In one embodiment, the package further comprises a dispensing nozzle through which the combined compositions are dispensed onto the skin. The aqueous and anhydrous compositions may be combined in the dispensing nozzle or a chamber leading thereto and then targeted onto the affected area of the skin.
- In one embodiment the package comprises a receptacle partitioned into first and second chambers. Preferably, the package comprises a dispensing nozzle in which the aqueous and anhydrous compositions may be combined before being expelled onto the skin.
- In another embodiment the package comprises a tube comprising an anhydrous or aqueous composition and an inner tube comprising the other of said anhydrous or aqueous composition. Suitably, the inner tube is encompassed within an outer tube which forms the packaging.
- Preferably, the package is squeezable to expel said anhydrous or aqueous compositions.
- It will be appreciated that a method according to the invention, including a method of treating acne comprising the topical administration of an acne active ingredient in the presence of a component that in the presence of water generates heat, may be a therapeutic method, but will often be a primarily cosmetic method, the objective of which is to reduce or eliminate externally visible, and often unsightly, symptoms of acne.
- The invention will now be described in more detail, by way of illustration only, with reference to the accompanying drawings.
- In the drawings:
-
FIG. 1 shows a side view of a package comprising an inner tube containing a first composition located within a clear outer tube containing a second composition; -
FIG. 2 shows a perspective view of one end of a tube comprising a first dispensing nozzle; -
FIG. 3 shows an end view of a second dispensing nozzle; -
FIG. 4 shows a sectional view of a partitioned package comprising first and second chambers; -
FIG. 5 shows an expanded perspective view of the dispensing nozzle from a partitioned package. - Referring firstly to
FIG. 1 , an acne treatment package (2) for dispensing first and second compositions onto the skin comprises an outer tube (4) which provides a first chamber and an inner tube (6) which provides a second chamber, the contents of the first chamber being isolated from the second chamber. The outer tube has a cap (8). - An aqueous composition which comprises an acne active ingredient is stored in said first (outer) chamber and an anhydrous composition which comprises an acne active ingredient and a component that in the presence of water generates heat on the skin is stored in said second (inner) chamber.
- In another embodiment, the anhydrous composition is present in the outer tube and the aqueous composition is present in the inner tube.
- In a further embodiment, the acne active ingredient is present in either one of the anhydrous or aqueous compositions.
- In a further embodiment, at least one surfactant is present in either one of or both of the anhydrous and aqueous compositions.
- Referring to
FIG. 2 , the package comprises a neck which forms a dispensing nozzle (10). The inner tube has an outlet leading into a central channel (12) of the dispensing nozzle. The outer tube has an outlet leading to a plurality of openings (14) around the periphery of the dispensing nozzle. - In use, the dispensing nozzle (10) is placed on or near the affected area of the skin and the outer and inner tubes squeezed simultaneously. The anhydrous composition is expelled through the central channel (12) and the aqueous composition is expelled from the plurality of openings (14). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
-
FIG. 3 shows an embodiment where the central passage (12) is enlarged towards the periphery of the dispensing nozzle and allows a greater amount of the composition in the inner tube to be expelled at a given time in relation to the amount of composition expelled from the openings (14) in the outer tube. -
FIG. 4 shows a section view of a partitioned package (16) providing first (18) and second (20) chambers. The anhydrous composition is stored in the first chamber (18). The aqueous composition is stored in the second chamber (20). -
FIG. 5 shows a perspective view of one end of the partitioned package (16) which is in the form of a tube. The package comprises a neck which forms a dispensing nozzle (22). The dispensing nozzle is divided down the middle to form two semi-circular channels. A first channel connects the first chamber (18) with a dispensing aperture (24). A second channel connects the second chamber (20) with a dispensing aperture (26). - When it is desired to apply the combined compositions to the skin, the dispensing nozzle (10) is placed on or near the affected area of the skin and the tube (16) squeezed. The anhydrous composition is expelled from the aperture (24) and the aqueous composition is expelled from the aperture (26). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
- In the following examples, there are described several preferred embodiments to illustrate the invention. However, it is to be understood that the invention is not to be limited to the specific embodiments.
- In the examples, the ingredients are available as follows; Carrier1 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer is available from Penreco under the trade name Versagel M-1600; Carrier2 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer and is available from Penreco under the trade name Versagel R-500; Thickener1 is a combination of Glyceryl Dibehenate, Tribehenin and Glyceryl Behenate and is available form Gattefosse under the tradename Compritol ATO 888; Thickener2 is polyoxyethylene cetyl ether available under the tradename Brij 56; Acrylates/Vinyl Isodecanoate crosspolymer is available from 3V under the tradename Stabylen-30; The polyamide resin is available from Arizona Chemical under the tradename Sylvaclear AF1900V; Triethanolamine laureth sulphate (TEA-LS) is available under the tradename Sunform-T7; cocamidopropyl betaine is available under the trade name Incronam 30; PEG-150 is available under the tradename Crothix liquid; PEG-150 Pentaerythrityl Tetrastearate is available from Crothix;
- Any one of the heating compositions illustrated below may be combined with any of the aqueous compositions illustrated below. The compositions are rubbed together on the skin and after a desired period may be rinsed off.
- The ingredients listed in each example below were combined by mixing according to conventional methods.
-
-
Examples Materials 1 2 3 4 Carrier1 38.5% 38.5% — — Carrier2 — — 38.5% 38.5% Light 45% 45% 45% 45% Mineral oil Salicylic 1.5% 1.5% 1.5% 1.5% acid MgCl2 15% — 15% — Zeolite — 15% — 15% -
-
Examples Materials 5 6 7 8 9 10 Carrier2 38.5% 25% 15.5% 15.5% — 13% Light 25% 31.8% 60% 60% 33.5% 35% Mineral oil Salicylic 1.5% 1.5% 1.5% 1.5% 1.5% 1.5 % acid Butylene 20% 26.7% — — 30% 15.5% glycol Thickener1 — — 8% 8% — — MgCl2 15% 15% — 15% — — Zeolite — — 15% — 15% 15% PEG-8 — — — — 10% 10% Thickener2 — — — — 10% 10% -
-
Examples Materials 11 12 13 14 Carrier2 13.5% 13.5% 7% — Light — — 68.5% 60.5% Mineral oil Salicylic 1.5% 1.5% 1.5% 1.5% acid Butylene 50% 45% — glycol Thickener1 — — 8% 8% Zeolite 15% 30% 15% 30% PEG-8 10% 5% — — Brij 56 10% 5% — — -
-
Examples Materials 15 16 17 Salicylic acid 1.5% 1.5% 1.5% Butylene glycol 40% 26% 25 % Glycerine 26% 40% 40% Acrylates/Vinyl — — 1% Isodecanoate crosspolymer Zeolite 25% 25% 25% PEG-8 7.5% 7.5% 7.5% -
-
Examples Materials 18 19 20 Salicylic acid 1.5% 1.5% 1.5% Butylene glycol 38.5% — — Light mineral oil — 59.5% 45.5% Carrier1 — — 15% MgCl2 35% 35% 35% PEG-8 5% — — polyamide resin 5% — — Polypropylene glycol (PPG)-14 15% — — Thickener1 — 4% 3% -
-
Examples Materials 21 22 23 24 25 Salicylic acid 1.5% 1.5% 1.5% 1.5% 1.5% Carrier1 27.5% 15% 15% 15% 15 % Thickener 1 6% 2.7% 8.2% 3% 6% Mineral oil 40% 45% 40% 45% 42.5% MgCl2 25% 35% 35% 35% 35% Fragrance — 0.3% 0.3% — — -
-
Materials 26 27 28 Salicylic acid 1.5% 1.5% 1.5% Carrier1 15% 10% 10% Thickener1 — 2.5% — Mineral oil 43.5% 48.5% 43.5% Sodium Dodecyl Sulfate 5% 2.5% 10% MgCl2 35% 35% 35% -
-
Materials 29 30 Salicylic acid 2% 2% Carrier1 15% 30% Mineral oil 48% 43% Sodium Dodecyl Sulfate 5% 5% MgCl2 30% 20% - The ingredients listed in each example below were combined by mixing according to conventional methods.
-
-
Examples Materials 31 32 33 34 Water 27% 20% 25% 25% Salicylic acid 1.5% 1.5% 1.5% 1.5% Butylene glycol 15% — — — Polyamide resin 3% — — — Glycerol — 25% 15% 15% Ethanol 45% 45% 45% 45% Menthol (L) 3.5% — 3.5% — Menthol (D/L) — 3.5% — 3.5% TEA - Laureth Sulphate — — 5% 5% PEG - 8 5% 5% 5% 5% -
-
Examples Materials 35 36 37 38 39 40 Salicylic acid 2% 2% 2% 2% 2% 2% Butylene glycol 35% 30% 20% 22% — 35% Glycerol 25% 20% 30% 30% 40% 25% PEG-7 glyceryl cocoate 2.5% 2.5% 4% 3% 2% 2% PEG-150 Pentaerythrityl 5% 5% 4% 4% 10% 3% Tetrastearate PEG-8 2.5% 2.5% 4% 3% 2% 3% polyamide resin 5% 15% 3% — — — PPG -14 butyl ether — — 10% 13% 13% — Water 13% 13% 13% 3% 21% 20% Sodium Lauryl Sulphate 10% 10% 10% 20% 10% — (30% in water) Cocamidopropyl Betaine — — — — — 10% -
-
Examples Materials 41 42 43 44 Salicylic acid 2% 2% 2% 2% Butylene glycol 35% 35% 30% 30 % Glycerol 20% 20% 20% 20% PEG-7 glyceryl cocoate 2% 2% 2% 2% PEG-8 2% 2% 2% 2% Hydrolysed milk protein 0.2% 0.2% 0.2% 0.2% PPG -14 butyl ether 10% 10% 5% 6% cocamidopropyl betaine — 2.3% 2.9% 2.8% Sodium Lauryl Sulphate 7.5% 5.3% 6.7% 6.7% (30% in water) Lanolin — — 1% 0.5% Stearyl alcohol — — 2% 1.5% Sodium Chloride 1% 1% 1% 1% PEG - 150 — — 3% 3% Water to 100% to 100% to 100% to 100% -
-
Examples Materials 45 46 47 48 49 Butylene Glycol 30% 30% 30% 30% 30 % Glycerine 20% 20% 20% 20% 20% PEG-7 1.5% 2% 2% 2.5% 2.5% PEG-8 1.5% 2% 2% 2.5% 2.5% PPG-14 6.5% 6.5% 6.5% 5% 5 % Lanolin 2% 2% 2% 2% 2% Stearyl Alcohol — — — 0.5% 1% PEG-150 3.5% 2.5% 2.5% 3% 3% Sodium lauryl 6.7% 6.7% 6.7% 6.1% 6.1% sulphate cocamidopropyl 2.8% 2.8% 2.8% 2.8% 2.8% betaine NaCl 1% 1% 1% 1% 1% Salicylic Acid 2% 2% 2% 2% 2% Hydrolysed Milk 0.2% 0.2% 0.2% 0.2% 0.2% Protein Water to 100% to 100% to 100% to 100% to 100% -
-
Examples Materials 50 51 52 53 54 Butylene Glycol 22.5 22.5 22.5 12.5 12.5 Glycerine 15 15 15 5 5 PEG-7 2.3 2.3 2.3 2.5 2.5 PEG-8 2.3 2.3 2.3 1.5 1.5 PPG-14 3.8 3.8 3.8 3.8 3.8 Lanolin 0.4 0.4 0.4 — — Protanal LF 10/600.4 — — — — Carrageenan — 0.4 1.5 — — Carbopol polymer — — — 1 3.8 Crothix Solid — — — 1.5 — Sodium lauryl 6.5 6.5 6.5 5 2 sulphate Incronam 2.1 2.1 2.1 2.1 2.1 NaCl 0.4 0.4 0.4 0.8 0.8 Salicylic Acid 1.5 1.5 1.5 1.5 1.5 Hydrolysed Milk 0.2 0.2 0.2 0.2 0.2 Protein Colour qs qs qs qs qs Fragrance qs qs qs qs qs water to 100% to 100% to 100% to 100% to 100% - Amounts are shown in g
-
-
Examples Materials 55 56 Butylene Glycol: 6.0000 6.0000 Glycerine: 3.0000 3.0000 PEG-7 1.5000 1.5000 PEG-8 1.5000 1.5000 PPG-14 3.0000 3.0000 S.L.S 7.5000 6.3750 Arrowroot 3.0000 4.5000 Incronam 1.0500 1.0500 Water: 44.6250 44.2500 Sodium chloride 0.7500 0.7500 Salicylic Acid 1.5000 1.5000 Hydrolysed Milk Protein 1.5000 1.5000 Colour qs qs Fragrance qs qs -
-
Examples Materials 57 58 59 60 Sodium hydroxide (25%) 0.86 0.86 0.34 0.8625 Carbopol CC polymer 3.75 3.75 — 11.2500 Glycerine 4.36 11.25 4.5 8.4375 PEG-7 1.125 1.125 13.5 0.8438 PEG-8 1.125 1.125 0.15 0.8438 S.L.S (27%) 7.5 — 1.13 22.5000 S.D.S solid — 15 1.13 — Cocamidopropyl 7.5 — 11.25 — betaine (30%) Water added 47.2 40.31 11.25 28.6875 Salicylic Acid 1.5 1.5 29.25 1.5000 Colour 0.0002 0.0002 1.5 0.0002 Fragrance 0.075 0.075 0.0002 0.0750 -
-
Examples Materials 61 62 Glycerine: 2.25 2.25 Water: 43.67 43.67 NaCl 0.94 0.94 Salicylic Acid 1.5 1.5 Hydrolysed Milk Protein 0.15 0.15 Colour 0.0003 0.0003 Fragrance 0.15 0.15 Sodium hydroxide @ 25% 0.14 0.14 Plantacare 818 UP 6 6 Texapon NSO 20.25 — Plantapon 611C — 20.25 -
-
Materials 63 64 Salicylic Acid 2 2 Colour qs qs Fragrance qs qs Cocoglucoside (50%) 8 8 Glycerin 2.7 2.7 Salt (NaCl) 1.2 Sodium Laureth-2 Sulphate 52 67.7 (27%) Levomenthol 0.1 — Hydrolysed milk protein 0.2 Sodium chloride 1.1 Water to 100% to 100% - A sheet of vitro-skin was accurately cut using a guillotine into 10 equal pieces. Each of these pieces was then numbered and weighed before the addition of sebum. Sebum was added to the skin as a solid that could be rubbed across the whole of the skin surface (matte side) until the whole surface was covered (˜0.2 g). Each piece of skin was then weighed once more before being placed in the hydration chamber.
- The hydration chamber was prepared by adding a mixture of Glycerine (44 g) and DI water (256 g) to the bottom of it. The skin was then placed on the contained shelves and allowed to stand, with the lid tightly in place for approximately 24 hours at ambient conditions in order to ensure a realistic level of vitro-skin hydration.
- After 24 hours the lid was removed and cleansing tests were carried out on the skin. For all tests, the vitro-skin was placed on a foam surface to mimic the non-solidity of skin.
- For all samples, 5 ml of DI water at room temperature was accurately syringed onto the surface of the vitro-skin. This was then massaged into the skin using a gloved finger with small circular movements for ten seconds. Once this was done the test sample was applied and massaged into the skin.
- After cleansing all skin samples were thoroughly rinsed until for a minimum of 30 seconds, or until all visible products had been removed (as would be the case in a realistic situation).
- After cleansing, the vitro-skin was left to dry on the shelves provided in the hydration chamber.
- After 24 hours the skin was then re-weighed providing the information that was required to then calculate the percentage of sebum removed from each piece of vitro-skin.
- All testing carried out on vitro-skin was repeated 5 times for each variable.
- The test samples were:
- A: Water
- B: Part 1—Anhydrous composition comprising mineral oil, surfactant, magnesium chloride and salicylic acid (2% w/w) as illustrated herein.
-
Part 2—Aqueous cleansing composition comprising surfactant and salicylic acid (2% w/w) as illustrated herein - C: Aqueous cleansing composition comprising surfactant and salicylic acid (2% w/w) as illustrated herein
- The test results were as follows:
-
Mass of Mass of Skin + Mass of % Mass of Skin + Sebum After Sebum Sebum Standard Skin. Sebum Cleansing Removed Removed Average Deviation Confidence A 0.601 0.798 0.705 0.093 47.2081 32.7214 12.5944 11.039280 0.599 0.808 0.779 0.029 13.8756 0.590 0.794 0.735 0.059 28.9216 0.568 0.762 0.697 0.065 33.5052 0.561 0.768 0.685 0.083 40.0966 B 0.581 0.782 0.668 0.114 56.7164 78.6322 5.29019 3.4561965 0.563 0.771 0.619 0.152 73.0769 0.565 0.754 0.608 0.146 77.2487 0.604 0.800 0.629 0.171 87.2449 0.598 0.783 0.630 0.153 82.7027 0.463 0.661 0.515 0.146 73.7374 0.457 0.637 0.503 0.134 74.4444 0.444 0.626 0.479 0.147 80.7692 0.467 0.679 0.522 0.157 74.0566 0.455 0.641 0.484 0.157 84.4086 C 0.617 0.830 0.704 0.126 59.1549 44.9166 13.0069 11.400818 0.580 0.790 0.670 0.120 57.1429 0.560 0.751 0.669 0.082 42.9319 0.577 0.758 0.693 0.065 35.9116 0.552 0.749 0.691 0.058 29.4416
Claims (37)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0800145.5 | 2008-01-04 | ||
| GBGB0800145.5A GB0800145D0 (en) | 2008-01-04 | 2008-01-04 | Skincare treatment |
| PCT/GB2008/004283 WO2009087354A2 (en) | 2008-01-04 | 2008-12-24 | Skincare treatment |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2008/004283 A-371-Of-International WO2009087354A2 (en) | 2008-01-04 | 2008-12-24 | Skincare treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/590,618 Division US11110044B2 (en) | 2008-01-04 | 2017-05-09 | Skincare treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20110121033A1 true US20110121033A1 (en) | 2011-05-26 |
Family
ID=39111155
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/811,705 Abandoned US20110121033A1 (en) | 2008-01-04 | 2008-12-24 | Skincare Treatment |
| US15/590,618 Expired - Fee Related US11110044B2 (en) | 2008-01-04 | 2017-05-09 | Skincare treatment |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/590,618 Expired - Fee Related US11110044B2 (en) | 2008-01-04 | 2017-05-09 | Skincare treatment |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110121033A1 (en) |
| EP (1) | EP2240184B1 (en) |
| AU (1) | AU2008346288B2 (en) |
| GB (1) | GB0800145D0 (en) |
| RU (1) | RU2010132650A (en) |
| WO (1) | WO2009087354A2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110138678A1 (en) * | 2008-01-31 | 2011-06-16 | Colin Smith | Insect trap |
| US20140147504A1 (en) * | 2012-11-27 | 2014-05-29 | Hovione International Ltd. | Tetracycline topical formulations, preparation and uses thereof |
| CN105324474A (en) * | 2013-06-18 | 2016-02-10 | 葛廷解决方案有限责任公司 | Compositions for removing stains and deposits |
| US20200123338A1 (en) * | 2017-07-11 | 2020-04-23 | Technion Research & Development Foundation Limited | Liquid-retaining elastomeric compositions, process of preparation and uses thereof |
| US11596641B2 (en) * | 2020-03-24 | 2023-03-07 | Hovione Scientia Limited | Methods and compositions for treating meibomian gland dysfunction |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0800145D0 (en) * | 2008-01-04 | 2008-02-13 | Reckitt Benckiser Uk Ltd | Skincare treatment |
| JP1665824S (en) | 2019-08-21 | 2020-08-11 | ||
| WO2021042127A1 (en) | 2019-08-30 | 2021-03-04 | The Procter & Gamble Company | A packaged hair care composition |
| EP4237097A1 (en) | 2020-10-27 | 2023-09-06 | The Procter & Gamble Company | Warming conditioner |
| USD1006632S1 (en) | 2020-12-11 | 2023-12-05 | The Procter & Gamble Company | Container for hair care products |
| USD1012718S1 (en) | 2020-12-21 | 2024-01-30 | The Procter & Gamble Company | Container for hair care product |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663716A (en) * | 1970-06-22 | 1972-05-16 | Miles Lab | Method of treating acne with benzyl alcohol |
| US4822604A (en) * | 1985-05-20 | 1989-04-18 | S. C. Johnson & Son, Inc. | Local treatment of dandruff, seborrheic dermatitis, and psoriasis |
| US5221534A (en) * | 1989-04-26 | 1993-06-22 | Pennzoil Products Company | Health and beauty aid compositions |
| WO2002060408A1 (en) * | 2001-02-01 | 2002-08-08 | The Procter & Gamble Company | Anhydrous cosmetic compositions |
| US20040208902A1 (en) * | 2003-04-18 | 2004-10-21 | Gupta Shyam K. | Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions |
| WO2005030160A1 (en) * | 2003-09-29 | 2005-04-07 | H.S.A. HAIR STYLING APPLICATIONS S.p.a. | A cosmetic product comprising a fruit component |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4318907A (en) * | 1978-04-04 | 1982-03-09 | Westwood Pharmaceuticals, Inc. | Method for treating acne vulgaris and compositions useful for that purpose |
| US4379143A (en) * | 1980-12-05 | 1983-04-05 | Pq Corporation | Topical liquid or ointment |
| EP0639068A1 (en) * | 1992-05-05 | 1995-02-22 | The Procter & Gamble Company | Acne treating composition |
| US5955067A (en) * | 1996-07-23 | 1999-09-21 | Oge; Eray | Potassium-containing composition useful in the treatment of acne, psoriasis and seborrhea |
| JP4316177B2 (en) * | 1999-07-08 | 2009-08-19 | ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド | Exothermic local feeder |
| JP2001187741A (en) * | 1999-12-28 | 2001-07-10 | Lion Corp | External pharmaceutical composition for skin |
| DE10237738A1 (en) * | 2002-08-17 | 2004-02-26 | Beiersdorf Ag | Self-heating composition, especially for skin cleansing or care, comprises two components stored in a package with one or two exit openings |
| GB0800145D0 (en) * | 2008-01-04 | 2008-02-13 | Reckitt Benckiser Uk Ltd | Skincare treatment |
-
2008
- 2008-01-04 GB GBGB0800145.5A patent/GB0800145D0/en not_active Ceased
- 2008-12-24 US US12/811,705 patent/US20110121033A1/en not_active Abandoned
- 2008-12-24 WO PCT/GB2008/004283 patent/WO2009087354A2/en not_active Ceased
- 2008-12-24 AU AU2008346288A patent/AU2008346288B2/en not_active Ceased
- 2008-12-24 RU RU2010132650/15A patent/RU2010132650A/en not_active Application Discontinuation
- 2008-12-24 EP EP08869610.9A patent/EP2240184B1/en active Active
-
2017
- 2017-05-09 US US15/590,618 patent/US11110044B2/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663716A (en) * | 1970-06-22 | 1972-05-16 | Miles Lab | Method of treating acne with benzyl alcohol |
| US4822604A (en) * | 1985-05-20 | 1989-04-18 | S. C. Johnson & Son, Inc. | Local treatment of dandruff, seborrheic dermatitis, and psoriasis |
| US5221534A (en) * | 1989-04-26 | 1993-06-22 | Pennzoil Products Company | Health and beauty aid compositions |
| WO2002060408A1 (en) * | 2001-02-01 | 2002-08-08 | The Procter & Gamble Company | Anhydrous cosmetic compositions |
| US20040208902A1 (en) * | 2003-04-18 | 2004-10-21 | Gupta Shyam K. | Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions |
| WO2005030160A1 (en) * | 2003-09-29 | 2005-04-07 | H.S.A. HAIR STYLING APPLICATIONS S.p.a. | A cosmetic product comprising a fruit component |
Non-Patent Citations (3)
| Title |
|---|
| Kubo et al., Journal of Natural Products. Vol. 57, No. 1, January 1994: pp. 9-17. * |
| Togashi et al. Molecules 2007, 12, 139-148. * |
| WO 2002/060408 ("Uchid") as evidenced by US 3,663,716 ("Stolar") as applied to claims 22-25, 27 and 37, in further view of US 4,822,604 * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8959831B2 (en) * | 2008-01-31 | 2015-02-24 | Colin Smith | Insect trap |
| US20110138678A1 (en) * | 2008-01-31 | 2011-06-16 | Colin Smith | Insect trap |
| US20170182071A1 (en) * | 2012-11-27 | 2017-06-29 | Hovione International Ltd. | Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition |
| US20140147504A1 (en) * | 2012-11-27 | 2014-05-29 | Hovione International Ltd. | Tetracycline topical formulations, preparation and uses thereof |
| CN104902875A (en) * | 2012-11-27 | 2015-09-09 | 好利安科学有限公司 | Tetracycline topical formulations, preparation and uses thereof |
| JP2016500095A (en) * | 2012-11-27 | 2016-01-07 | ホビオネ サイエンティア リミテッド | Tetracycline topical formulation, its preparation and use |
| US10213443B2 (en) * | 2012-11-27 | 2019-02-26 | Hovione Scientia Limited | Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition |
| US9592246B2 (en) * | 2012-11-27 | 2017-03-14 | Hovione International Ltd. | Tetracycline topical formulations, preparation and uses thereof |
| US20160137955A1 (en) * | 2013-06-18 | 2016-05-19 | Geting Solutions Gmbh | Agent for removing stains and deposits |
| US10047322B2 (en) * | 2013-06-18 | 2018-08-14 | Buck Service Gmbh | Agent for removing stains and deposits comprising an alkylene styrene copolymer |
| CN105324474A (en) * | 2013-06-18 | 2016-02-10 | 葛廷解决方案有限责任公司 | Compositions for removing stains and deposits |
| CN105324474B (en) * | 2013-06-18 | 2019-09-13 | 巴克服务有限责任公司 | Composition for removing stains and deposits |
| US20200123338A1 (en) * | 2017-07-11 | 2020-04-23 | Technion Research & Development Foundation Limited | Liquid-retaining elastomeric compositions, process of preparation and uses thereof |
| US11596641B2 (en) * | 2020-03-24 | 2023-03-07 | Hovione Scientia Limited | Methods and compositions for treating meibomian gland dysfunction |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2240184B1 (en) | 2017-03-08 |
| AU2008346288A1 (en) | 2009-07-16 |
| AU2008346288B2 (en) | 2015-03-26 |
| US11110044B2 (en) | 2021-09-07 |
| EP2240184A2 (en) | 2010-10-20 |
| US20170246093A1 (en) | 2017-08-31 |
| RU2010132650A (en) | 2012-02-10 |
| WO2009087354A2 (en) | 2009-07-16 |
| WO2009087354A3 (en) | 2009-11-26 |
| GB0800145D0 (en) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11110044B2 (en) | Skincare treatment | |
| ES2197457T3 (en) | CLEANING COMPOSITION WITH CLEANING BASE AND ADVANTAGE BASE THAT ARE DISPERSED SEPARATELY IN WHICH THE ADVANTAGE BASE ALSO CONTAINS TENSIOACTIVE. | |
| RU2695615C1 (en) | Foaming composition containing at least one surfactant of glycinate type | |
| AU2015238222B2 (en) | Rinse-off chemical mousse containing benzoyl peroxide | |
| WO2010069995A1 (en) | Silicone-free transparent two-phase composition | |
| US20140366907A1 (en) | Composition for the oxidation dyeing of keratin fibres, comprising particular fatty alcohols, a liquid fatty substance and a cationic polymer | |
| BRPI0713182A2 (en) | adaptalene uses of one of its pharmaceutically acceptable salts, kit and product | |
| JP2011136992A (en) | Cosmetic cleansing composition containing jasmonic acid derivative and surfactant | |
| FR2993177A1 (en) | BIPHASIC COMPOSITION CONTAINING ALKYLPOLYGLUCOSIDE AND A FUSION POINT ESTER LESS THAN 10 ° C | |
| BR102016022176A2 (en) | compositions and methods for treating blackheads | |
| ES2280629T3 (en) | DAPSONE TOPICO FOR THE TREATMENT OF ACNE. | |
| BR112017009270B1 (en) | COMPOSITIONS FOR PERSONAL CARE, SKIN CLEANING METHOD AND KIT | |
| ES2990101T3 (en) | Personal care compositions and methods comprising trans-1-chloro-3,3,3-trifluoropropene and trans-1,3,3,3-tetrafluoropropene | |
| CN106456472A (en) | Composition with optical effects | |
| JP2004285047A (en) | Transparent two-phase composition for topical application | |
| EP2046273A2 (en) | Rinse-off therapeutic agents for treating skin | |
| US20110059035A1 (en) | Compositions based on polymer/hydrogen peroxide complexes and uses thereof | |
| ES2282824T3 (en) | BIFASSIC COMPOSITION AND ITS USE IN COSMETICS. | |
| US20200146969A1 (en) | Dead sea salts cosmetic compositions | |
| CN109875906A (en) | Preservative Enhancer | |
| CN104869979A (en) | Cosmetic compositions, cosmetic methods for cleansing keratin, and uses thereof | |
| AU2015202797A1 (en) | Skincare treatment | |
| BRPI1007164B1 (en) | a topical composition comprising a depilatory agent, an agent for preventing or reducing hair growth and another for preventing or reducing hair interlocking, a hair removal method, and a method for preventing or reducing hair growth | |
| JP6770339B2 (en) | Miconazole nitrate-containing composition | |
| WO2018114800A1 (en) | Composition comprising an amps polymer, montmorillonite, silica and kaolin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: RECKITT BENCKISER (UK) LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HORNE, REBECCA;KELLY, DIANE;KIRCHHOFFER, LAURENT;AND OTHERS;SIGNING DATES FROM 20100827 TO 20101126;REEL/FRAME:025496/0867 |
|
| AS | Assignment |
Owner name: RECKITT & COLMAN (OVERSEAS) LIMITED, UNITED KINGDO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RECKITT BENCKISER (UK) LIMITED;REEL/FRAME:026215/0297 Effective date: 20110419 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |